Literature DB >> 25024389

Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ-producing T cells.

Taizo Mori1, Yukiko Iwasaki2, Yoichi Seki1, Masanori Iseki1, Hiroko Katayama1, Kazuhiko Yamamoto3, Kiyoshi Takatsu4, Satoshi Takaki5.   

Abstract

Dendritic cells (DCs) are proficient APCs that play crucial roles in the immune responses to various Ags and pathogens and polarize Th cell immune responses. Lnk/SH2B adaptor protein 3 (Sh2b3) is an intracellular adaptor protein that regulates B lymphopoiesis, megakaryopoiesis, and expansion of hematopoietic stem cells by constraining cytokine signals. Recent genome-wide association studies have revealed a link between polymorphism in this adaptor protein and autoimmune diseases, including type 1 diabetes and celiac disease. We found that Lnk/Sh2b3 was also expressed in DCs and investigated its role in the production and function of DC lineage cells. In Lnk(-/-) mice, DC numbers were increased in the spleen and lymph nodes, and growth responses of bone marrow-derived DCs to GM-CSF were augmented. Mature DCs from Lnk(-/-) mice were hypersensitive and showed enhanced responses to IL-15 and GM-CSF. Compared to normal DCs, Lnk(-/-) DCs had enhanced abilities to support the differentiation of IFN-γ-producing Th1 cells from naive CD4(+) T cells. This was due to their elevated expression of IL-12Rβ1 and increased production of IFN-γ. Lnk(-/-) DCs supported the appearance of IFN-γ-producing T cells even under conditions in which normal DCs supported induction of regulatory T cells. These results indicated that Lnk/Sh2b3 plays a regulatory role in the expansion of DCs and might influence inflammatory immune responses in peripheral lymphoid tissues.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25024389     DOI: 10.4049/jimmunol.1303243

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis.

Authors:  Johannes Waage; Marie Standl; John A Curtin; Leon E Jessen; Jonathan Thorsen; Chao Tian; Nathan Schoettler; Carlos Flores; Abdel Abdellaoui; Tarunveer S Ahluwalia; Alexessander C Alves; Andre F S Amaral; Josep M Antó; Andreas Arnold; Amalia Barreto-Luis; Hansjörg Baurecht; Catharina E M van Beijsterveldt; Eugene R Bleecker; Sílvia Bonàs-Guarch; Dorret I Boomsma; Susanne Brix; Supinda Bunyavanich; Esteban G Burchard; Zhanghua Chen; Ivan Curjuric; Adnan Custovic; Herman T den Dekker; Shyamali C Dharmage; Julia Dmitrieva; Liesbeth Duijts; Markus J Ege; W James Gauderman; Michel Georges; Christian Gieger; Frank Gilliland; Raquel Granell; Hongsheng Gui; Torben Hansen; Joachim Heinrich; John Henderson; Natalia Hernandez-Pacheco; Patrick Holt; Medea Imboden; Vincent W V Jaddoe; Marjo-Riitta Jarvelin; Deborah L Jarvis; Kamilla K Jensen; Ingileif Jónsdóttir; Michael Kabesch; Jaakko Kaprio; Ashish Kumar; Young-Ae Lee; Albert M Levin; Xingnan Li; Fabian Lorenzo-Diaz; Erik Melén; Josep M Mercader; Deborah A Meyers; Rachel Myers; Dan L Nicolae; Ellen A Nohr; Teemu Palviainen; Lavinia Paternoster; Craig E Pennell; Göran Pershagen; Maria Pino-Yanes; Nicole M Probst-Hensch; Franz Rüschendorf; Angela Simpson; Kari Stefansson; Jordi Sunyer; Gardar Sveinbjornsson; Elisabeth Thiering; Philip J Thompson; Maties Torrent; David Torrents; Joyce Y Tung; Carol A Wang; Stephan Weidinger; Scott Weiss; Gonneke Willemsen; L Keoki Williams; Carole Ober; David A Hinds; Manuel A Ferreira; Hans Bisgaard; David P Strachan; Klaus Bønnelykke
Journal:  Nat Genet       Date:  2018-07-16       Impact factor: 38.330

Review 2.  Linking inflammation and hypertension via LNK/SH2B3.

Authors:  Bethany L Dale; Meena S Madhur
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-03       Impact factor: 2.894

3.  Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.

Authors:  Carolina E Morales; Elliot Stieglitz; Scott C Kogan; Mignon L Loh; Benjamin S Braun
Journal:  Blood Adv       Date:  2021-09-28

Review 4.  The function of SH2B3 (LNK) in the kidney.

Authors:  Gregory Blass; David L Mattson; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

Review 5.  Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.

Authors:  Chie Hotta-Iwamura; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2016-01-20       Impact factor: 4.962

6.  Genomic Strategies Toward Identification of Novel Therapeutic Targets.

Authors:  Thorsten Kessler; Heribert Schunkert
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.

Authors:  James Bentham; David L Morris; Deborah S Cunninghame Graham; Christopher L Pinder; Philip Tombleson; Timothy W Behrens; Javier Martín; Benjamin P Fairfax; Julian C Knight; Lingyan Chen; Joseph Replogle; Ann-Christine Syvänen; Lars Rönnblom; Robert R Graham; Joan E Wither; John D Rioux; Marta E Alarcón-Riquelme; Timothy J Vyse
Journal:  Nat Genet       Date:  2015-10-26       Impact factor: 38.330

Review 8.  The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease.

Authors:  Thorsten Kessler; Baiba Vilne; Heribert Schunkert
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

9.  Exploring the Genetic Correlation Between Growth and Immunity Based on Summary Statistics of Genome-Wide Association Studies.

Authors:  Zhe Zhang; Peipei Ma; Qiumeng Li; Qian Xiao; Hao Sun; Babatunde Shittu Olasege; Qishan Wang; Yuchun Pan
Journal:  Front Genet       Date:  2018-09-14       Impact factor: 4.599

10.  Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.

Authors:  Akiko Nagasu; Tomoyuki Mukai; Masanori Iseki; Kyoko Kawahara; Shoko Tsuji; Hajime Nagasu; Yasuyoshi Ueki; Katsuhiko Ishihara; Naoki Kashihara; Yoshitaka Morita
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.